nestl s unexpected sales growth

Nestlé Defies Market Skeptics With Surprising H2 2025 Organic Sales Surge

How Nestlé's 2025 sales surge defied skeptics—yet hidden hurdles expose why rivals are nervous. A 4% stock jump stirs alarm as pricing risks loom.

Despite facing strong currency headwinds, Nestlé posted unexpected organic sales growth of 2.9% in the initial half of 2025, narrowly beating analyst forecasts. The slight upside came despite a 4.7% currency hit from Swiss franc strength, which pushed total sales down 1.8% to 44.2 billion CHF. The company’s strategic transformation under new CEO Laurent Freixe, who took charge in August 2024, showed early results through aggressive pricing strategy. Price increases contributed 2.7 percentage points to organic growth, outpacing volume gains.

Nestlé reported 2.9% organic growth in H1 2025 despite 4.7% currency pressures, with strategic pricing under CEO Freixe driving 2.7 points of gains.

Confectionery and coffee led growth, with confectionery prices jumping 10.6% and coffee rising 6.0%. Mocha calories maintained stable volumes, while confectionery saw some short-term sales dips due to price sensitivity. Nespresso thrived due to premium innovation like Vertuo and limited-edition launches, particularly in North America.

Regional performance diverged: North America lagged with low single-digit growth, while Europe delivered stronger mid-single-digit gains despite tough competition in Western markets. Emerging markets supported growth but received less focus in reporting. The company also accelerated its Greater China expansion, launching region-specific health nutrition products to capitalize on growing demand for imported supplements.

The nutrition division saw mixed results. Vitamins and supplements grew modestly, premium brands like Pure Encapsulations rose, but budget options declined. Nestlé’s ongoing strategic vitamins review targets underperforming brands such as Natures Bounty and Osteo Bi-Flex as part of efforts to optimize the portfolio. Medical Nutrition surged almost 10%, driven by allergy and pediatric products. Active Nutrition edged up as Orgain gained ground, though essential Proteins softened.

Nestlé is reviewing its vitamins business for potential divestments, signaling sharper focus under Freixe’s turnaround plan. Nestlé’s shares rose 4% in 2025 but still trail rivals like Unilever. Chairman Paul Bulcke stepped down amid governance concerns, adding pressure for faster change.

Despite currency drags, management kept its full-year outlook, aiming for stable 16%+ operating margins. Pricing agility proved critical—executives balanced hikes against demand risks, testing how far prices could rise without alienating shoppers. Investors now watch whether Nestlé can sustain momentum through innovation and cost discipline while steering through volatile currency markets.

The firm’s ability to squeeze growth from core categories while reshaping weaker segments might determine its path to catching up with peers.

×
Fresh. Fast. Free.

Get fast, free delivery on your fresh favorite coffee beans with

Try Amazon Prime Free
Scroll to Top